| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1997) |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| ATC: | L04AC01 |
| UNII: | CUJ2MVI71Y |
Pharmacology
| Primary Target | |
|---|---|
| Interleukin-2 receptor subunit α |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference | ||
|---|---|---|---|---|---|
| Multiple Sclerosis, Relapsing-Remitting | 4 | D020529 | FDA | ||
| Graft vs Host Disease | 3 | D006086 | ClinicalTrials | ||
| Multiple Sclerosis | 3 | D009103 | ClinicalTrials | ||
| Diabetes Mellitus, Type 1 | 3 | D003922 | ClinicalTrials | ||
| Renal Insufficiency, Chronic | 3 | D051436 | ClinicalTrials | ||
| Asthma | 2 | D001249 | ClinicalTrials | ||
| Leukemia | 2 | D007938 | ClinicalTrials | ||
| Uveitis | 2 | D014605 | ClinicalTrials | ||
| Thrombocytopenia | 2 | D013921 | ClinicalTrials | ||
| Anemia, Aplastic | 2 | D000741 | ClinicalTrials | ||
| Red-Cell Aplasia, Pure | 2 | D012010 | ClinicalTrials | ||
| Wet Macular Degeneration | 2 | D057135 | ClinicalTrials | ||
| Myelodysplastic Syndromes | 2 | D009190 | ClinicalTrials | ||
| Diabetes Mellitus | 2 | D003920 | ClinicalTrials | ||
| Colitis, Ulcerative | 2 | D003093 | ClinicalTrials | ||
| Red-Cell Aplasia, Pure | 2 | D012010 | ClinicalTrials | ||
| Multiple Myeloma | 2 | D009101 | ClinicalTrials | ||
| Granulomatosis with Polyangiitis | 2 | D014890 | ClinicalTrials | ||
| Lymphoma | 1 | D008223 | ClinicalTrials | ||
| Neoplasms | 1 | D009369 | ClinicalTrials | ||
| Kidney Diseases | 1 | D007674 | ClinicalTrials | ||
| Melanoma | 1 | D008545 | ClinicalTrials | ||
| HIV Infections | 1 | D015658 | ClinicalTrials | ||
| Psoriasis | 1 | D011565 | ClinicalTrials | ||
| DiGeorge Syndrome | 1 | D004062 | ClinicalTrials |
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 152923-56-3 |
| ChEMBL | CHEMBL1201605 |
| FDA SRS | CUJ2MVI71Y |
| Guide to Pharmacology | 6880 |
CONTENTS